In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-16 of 16 for your search:
Cancer Type/Condition:  Acute lymphocytic leukemia (ALL), child
Trial Type:  Treatment
Treatment/Intervention:  allogeneic bone marrow transplantation, allogeneic hematopoietic stem cell transplantation, autologous bone marrow transplantation, autologous hematopoietic stem cell transplantation, hematopoietic stem cell transplantation, high-dose chemotherapy, high-dose chemotherapy with autologous stem cell rescue, Stem Cell Transplantation
Trial Status:  Active
Trial Phase:  Phase III
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 0 to 18
Sponsor: Other
Protocol IDs: CHU-0060, NCT01007617
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 50
Sponsor: Other
Protocol IDs: HORCSCT-0902, NCT01015742
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: Other
Protocol IDs: CDR0000686545, GPOH-COALL-08-09, EUDRACT-2009-012758-18, EU-21076, NCT01228331
4.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000732604, COG-ANHL1131, ANHL1131, NCT01595048
5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, COG-AALL0433, CDR0000495359, NCT00381680
6.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: CDR0000500131, COG-ASCT0431, COG-PBMTC-ONCO51, ASCT0431, NCT00382109
7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0307, NCT00619879
8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: CDR0000613220, MOTOL-ALL-IC-BFM-2002, EU-20871, ALL-IC-BFM-2002, NCT00764907
9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057
10.

Phase: Phase III
Type: Health services research, Treatment
Status: Active
Age: Under 35
Sponsor: Other
Protocol IDs: 2009-17, 2009-A00792-55, NCT01067300
11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P01CA018029, NCT01231412
12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 30
Sponsor: NCI, Other
Protocol IDs: CDR0000706370, COG-AALL1131, AALL1131, NCT01406756
13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 6 months to 17 years
Sponsor: Other
Protocol IDs: Inter B-NHL Ritux 2010 Phase 3, 2010-019224-31, NCT01516580
14.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, AALL0434, CDR0000514500, COG-AALL0434, U01CA98543, NCT00408005
15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Busulfan-2013, NCT01800643
16.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: Under 18
Sponsor: Other
Protocol IDs: IntReALL SR 2010, NCT01802814
New Search